{
    "id": "0402",
    "question": "A 27-year-old woman with a history of bipolar disorder presents for a 3-month follow-up after starting treatment with lithium. She says she has been compliant with her medication but has experienced no improvement. The patient has no other significant past medical history and takes no other medications. She reports no known allergies. The patient is afebrile, and her vital signs are within normal limits. A physical examination is unremarkable. The patient is switched to a different medication. The patient presents 2 weeks later with an acute onset rash on her torso consisting of targetoid lesions with a vesicular center. She says the rash developed 2 days ago which has progressively worsened. She also says that 1 week ago she developed fever, lethargy, myalgia, and chills that resolved in 3 days. Which of the following drugs was this patient most likely prescribed?",
    "options": {
        "A": "Lamotrigine",
        "B": "Valproate",
        "C": "Olanzapine-fluoxetine combination (OFC)",
        "D": "Paroxetine"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To solve this question, let's break down the key points from the scenario: 1. The patient has a history of bipolar disorder and was initially treated with lithium but experienced no improvement. 2. The patient was switched to a different medication. 3. The patient presents with a new rash, including targetoid lesions with a vesicular center, 2 weeks after the medication change. 4. The patient also experienced a recent episode of fever, lethargy, myalgia, and chills that resolved in 3 days. Considering the symptoms of the rash and the recent history of fever and other systemic symptoms, we can start to narrow down the potential medications. Lamotrigine (A) is known to cause skin rash, but it's more commonly associated with a maculopapular rash rather than targetoid lesions. Valproate (B) can cause skin rash, but it's not typically associated with the specific symptoms described. Olanzapine-fluoxetine combination (C) is an antidepressant, and fluoxetine is not known to cause the symptoms described. Paroxetine (D) is an SSRI, and SSRIs are known to cause a skin rash, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are severe skin conditions. The symptoms described, including the targetoid lesions and the recent episode of fever and other systemic symptoms, are consistent with SJS or TEN. Given the patient's history of bipolar disorder and the symptoms described, the most likely medication responsible is an SSRI, making Paroxetine (D) the most likely answer.\"} \"answer_choice\": \"D\"",
    "snippets": [],
    "scores": [],
    "execution_time": 40.14321565628052
}